Rainbow Seed Fund, the Oxford, UK-based early-stage venture capital fund focusing on promising technologies developed at publicly-funded research facilities and campuses, has announced it has now leveraged more than £200mMidven of private investment to support innovative companies.
Launched in 2002 and managed by Midven , Rainbow Seed Fund has been investing in more than 30 science technology startups in sectors such as health, environmental services, international development and security.
Led by Dr Andrew Muir, Investment Director, Rainbow has invested in Tokamak Energy, Cobalt Light Systems, Crescendo Biologics, Synthace, Spectral Edge, International GeoScience Services (IGS), Oxsensis, Oxford Space Systems (OSS), etc.
The £200m leverage represents a ratio of over £20 for every £1 invested from Rainbow.
Fund partners include UK public sector research establishments led by STFC (Science and Technology Facilities Council), BBSRC (Biotechnology and Biological Sciences Research Council), NERC and Dstl (Defence Science and Technology Laboratory).